EDP-26

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameEDP-26
Drug Alias NameEDP-26
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium voltage-gated channel subfamily KQT member 4 modulatorsPotassium Voltage-Gated Channel Subfamily Q Member 5 modulatorsVanilloid receptor modulators
TargetsPotassium voltage-gated channel subfamily KQT member 4Transient receptor potential cation channel subfamily V member 1Potassium Voltage-Gated Channel Subfamily Q Member 5
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTel Aviv University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiolinerx LtdTel Aviv University
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A